Kengo Nakahara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kengo Nakahara has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
- Nobumasa Takasugi
Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan
7 shared publications - Takashi Uehara
Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan
7 shared publications Kana Fujikawa
Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan
3 shared publicationsAkihiro Ito
School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, Tokyo, 192-0355, Japan
2 shared publicationsHideki Hiraoka
Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University
2 shared publicationsKosaku Okuda
Department of Medicinal Pharmacology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan
2 shared publications
Latest Publications
- Open Access
- 4 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis
DNA methyltransferases (DNMTs) catalyze methylation at the C5 position of cytosine withS-adenosyl-l-methionine. Methylation regulates gene expression, serving a variety of physiological and pathophysiological roles. The chemical mechanisms regulating DNMT enzymatic activity, however, are not fully elucidated. Here, we show that protein S-nitrosylation of a cysteine residue in DNMT3B attenuates DNMT3B enzymatic activity and consequent aberrant upregulation of gene expression. These genes include Cyclin D2 (Ccnd2), which is required for neoplastic cell proliferation in some tumor types. In cell-based and in vivo cancer models, only DNMT3B enzymatic activity, and not DNMT1 or DNMT3A, affectsCcnd2expression. Using structure-based virtual screening, we discovered chemical compounds that specifically inhibitS-nitrosylation without directly affecting DNMT3B enzymatic activity. The lead compound, designated DBIC, inhibitsS-nitrosylation of DNMT3B at low concentrations (IC50 ≤ 100 nM). Treatment with DBIC prevents nitric oxide (NO)-induced conversion of human colonic adenoma to adenocarcinoma in vitro. Additionally, in vivo treatment with DBIC strongly attenuates tumor development in a mouse model of carcinogenesis triggered by inflammation-induced generation of NO. Our results demonstrate that de novo DNA methylation mediated by DNMT3B is regulated by NO, and DBIC protects against tumor formation by preventing aberrantS-nitrosylation of DNMT3B.
- 4 February 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-16
Open AccessPivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis
DNA methyltransferases (DNMTs) catalyze methylation at the C5 position of cytosine withS-adenosyl-l-methionine. Methylation regulates gene expression, serving a variety of physiological and pathophysiological roles. The chemical mechanisms regulating DNMT enzymatic activity, however, are not fully elucidated. Here, we show that protein S-nitrosylation of a cysteine residue in DNMT3B attenuates DNMT3B enzymatic activity and consequent aberrant upregulation of gene expression. These genes include Cyclin D2 (Ccnd2), which is required for neoplastic cell proliferation in some tumor types. In cell-based and in vivo cancer models, only DNMT3B enzymatic activity, and not DNMT1 or DNMT3A, affectsCcnd2expression. Using structure-based virtual screening, we discovered chemical compounds that specifically inhibitS-nitrosylation without directly affecting DNMT3B enzymatic activity. The lead compound, designated DBIC, inhibitsS-nitrosylation of DNMT3B at low concentrations (IC50 ≤ 100 nM). Treatment with DBIC prevents nitric oxide (NO)-induced conversion of human colonic adenoma to adenocarcinoma in vitro. Additionally, in vivo treatment with DBIC strongly attenuates tumor development in a mouse model of carcinogenesis triggered by inflammation-induced generation of NO. Our results demonstrate that de novo DNA methylation mediated by DNMT3B is regulated by NO, and DBIC protects against tumor formation by preventing aberrantS-nitrosylation of DNMT3B.
- Open Access
- 1 January 2022
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 95, 1-57
Regulation of Gene Expression via Protein Oxidation
Epigenetic dysregulation, such as aberrant DNA methylation, is one of the hallmarks of cancer cells, however the mechanisms by which these dysregulations occur remain unclear. Previously, we found that DNA methyltransferase 3B (DNMT3B), which catalyzes cytosine methylation, is selectively oxidized by several stresses. A cysteine residue is the modification site on DNMT3B. As oxidation of DNMT3B attenuates its enzymatic activity, this reaction may be related to the epigenetic regulation. In this study, we focused on the cell cycle regulator CCND2 and examined whether its expression is regulated by oxidative stress and enzymatic activity of DNMT3B. Indeed, exposure to the stress and the universal DNMT inhibitor 5-aza-2'-deoxycytidine induced CCND2 expression. When DNMT1, DNMT3A, and DNMT3B were overexpressed, only DNMT3B significantly reduced CCND2 mRNA levels. CS mutant, which lost enzymatic activity, had no effect on CCND2 mRNA levels compared with the wild type. The siRNA knockdown of DNMT3B markedly enhanced CCND2 mRNA levels. Our data strongly suggest DNMT3B-specific regulation of CCND2 expression. Finally, bisulfite sequencing analysis revealed that oxidative stress significantly decreased DNA methylation levels in the CCND2 promoter region. These results indicate that oxidation of DNMT3B plays an important role in epigenetic regulation and may lead us to know the mechanism of epigenetic dysregulation in cancer cells.
- 1 January 2022
- Published by Japanese Pharmacological Society in Proceedings for Annual Meeting of The Japanese Pharmacological Society
- Vol. 95, 1-57
Open AccessRegulation of Gene Expression via Protein Oxidation
Epigenetic dysregulation, such as aberrant DNA methylation, is one of the hallmarks of cancer cells, however the mechanisms by which these dysregulations occur remain unclear. Previously, we found that DNA methyltransferase 3B (DNMT3B), which catalyzes cytosine methylation, is selectively oxidized by several stresses. A cysteine residue is the modification site on DNMT3B. As oxidation of DNMT3B attenuates its enzymatic activity, this reaction may be related to the epigenetic regulation. In this study, we focused on the cell cycle regulator CCND2 and examined whether its expression is regulated by oxidative stress and enzymatic activity of DNMT3B. Indeed, exposure to the stress and the universal DNMT inhibitor 5-aza-2'-deoxycytidine induced CCND2 expression. When DNMT1, DNMT3A, and DNMT3B were overexpressed, only DNMT3B significantly reduced CCND2 mRNA levels. CS mutant, which lost enzymatic activity, had no effect on CCND2 mRNA levels compared with the wild type. The siRNA knockdown of DNMT3B markedly enhanced CCND2 mRNA levels. Our data strongly suggest DNMT3B-specific regulation of CCND2 expression. Finally, bisulfite sequencing analysis revealed that oxidative stress significantly decreased DNA methylation levels in the CCND2 promoter region. These results indicate that oxidation of DNMT3B plays an important role in epigenetic regulation and may lead us to know the mechanism of epigenetic dysregulation in cancer cells.
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100524
Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor
- 1 January 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 296, 100524
Open AccessCovalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor
- Open Access
- 1 June 2019
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 42 (6) , 1044-1047
Attenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation
Nitric oxide (NO) is a key signaling molecule that has various effects via S-nitrosylation, a reversible post-translational modification that affects the enzymatic activity, localization, and metabolism of target proteins. As chronic nitrosative stress correlates with neurodegeneration, the targets have received focused attention. Macrophage migration inhibitory factor (MIF) plays a pivotal role in the induction of gene expression to control inflammatory responses. MIF acts as a ligand for CD74 receptor and activates the Src-p38 mitogen-activated protein kinase (MAPK) cascade. MIF also elevates the expression of brain-derived neurotrophic factor (BDNF), which contributes to the viability of neurons. Here, we show that MIF is S-nitrosylated by a physiological NO donor. Interestingly, the induction of S-nitrosylation resulted in a loss of MIF activity following stimulation of the Src and p38 MAPK signaling pathways and the induction of BDNF expression. Our results shed light on the pathogenic mechanisms of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.
- 1 June 2019
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 42 (6) , 1044-1047
Open AccessAttenuation of Macrophage Migration Inhibitory Factor-Stimulated Signaling via S-Nitrosylation
Nitric oxide (NO) is a key signaling molecule that has various effects via S-nitrosylation, a reversible post-translational modification that affects the enzymatic activity, localization, and metabolism of target proteins. As chronic nitrosative stress correlates with neurodegeneration, the targets have received focused attention. Macrophage migration inhibitory factor (MIF) plays a pivotal role in the induction of gene expression to control inflammatory responses. MIF acts as a ligand for CD74 receptor and activates the Src-p38 mitogen-activated protein kinase (MAPK) cascade. MIF also elevates the expression of brain-derived neurotrophic factor (BDNF), which contributes to the viability of neurons. Here, we show that MIF is S-nitrosylated by a physiological NO donor. Interestingly, the induction of S-nitrosylation resulted in a loss of MIF activity following stimulation of the Src and p38 MAPK signaling pathways and the induction of BDNF expression. Our results shed light on the pathogenic mechanisms of neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease.
- Open Access
- 10 April 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (7) , 1783
The Emerging Role of Electrophiles as a Key Regulator for Endoplasmic Reticulum (ER) Stress
The unfolded protein response (UPR) is activated by the accumulation of misfolded proteins in the endoplasmic reticulum (ER), which is called ER stress. ER stress sensors PERK, IRE1, and ATF6 play a central role in the initiation and regulation of the UPR; they inhibit novel protein synthesis and upregulate ER chaperones, such as protein disulfide isomerase, to remove unfolded proteins. However, when recovery from ER stress is difficult, the UPR pathway is activated to eliminate unhealthy cells. This signaling transition is the key event of many human diseases. However, the precise mechanisms are largely unknown. Intriguingly, reactive electrophilic species (RES), which exist in the environment or are produced through cellular metabolism, have been identified as a key player of this transition. In this review, we focused on the function of representative RES: nitric oxide (NO) as a gaseous RES, 4-hydroxynonenal (HNE) as a lipid RES, and methylmercury (MeHg) as an environmental organic compound RES, to outline the relationship between ER stress and RES. Modulation by RES might be a target for the development of next-generation therapy for ER stress-associated diseases.
- 10 April 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (7) , 1783
Open AccessThe Emerging Role of Electrophiles as a Key Regulator for Endoplasmic Reticulum (ER) Stress
The unfolded protein response (UPR) is activated by the accumulation of misfolded proteins in the endoplasmic reticulum (ER), which is called ER stress. ER stress sensors PERK, IRE1, and ATF6 play a central role in the initiation and regulation of the UPR; they inhibit novel protein synthesis and upregulate ER chaperones, such as protein disulfide isomerase, to remove unfolded proteins. However, when recovery from ER stress is difficult, the UPR pathway is activated to eliminate unhealthy cells. This signaling transition is the key event of many human diseases. However, the precise mechanisms are largely unknown. Intriguingly, reactive electrophilic species (RES), which exist in the environment or are produced through cellular metabolism, have been identified as a key player of this transition. In this review, we focused on the function of representative RES: nitric oxide (NO) as a gaseous RES, 4-hydroxynonenal (HNE) as a lipid RES, and methylmercury (MeHg) as an environmental organic compound RES, to outline the relationship between ER stress and RES. Modulation by RES might be a target for the development of next-generation therapy for ER stress-associated diseases.
- Open Access
- 1 January 2017
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 40 (9) , 1595-1598
Modulation of Unfolded Protein Response by Methylmercury
Methylmercury (MeHg) results in cell death through endoplasmic reticulum (ER) stress. Previously, we reported that MeHg induces S-mercuration at cysteine 383 or 386 in protein disulfide isomerase (PDI), and this modification induces the loss of enzymatic activity. Because PDI is a key enzyme for the maturation of nascent protein harboring a disulfide bond, the disruption in PDI function by MeHg results in ER stress via the accumulation of misfolded proteins. However, the effects of MeHg on unfolded protein response (UPR) sensors and their signaling remain unclear. In the present study, we show that UPR is regulated by MeHg. We found that MeHg specifically attenuated inositol-requiring enzyme 1α (IRE1α)–x-box binding protein 1 (XBP1) branch, but not the protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating transcriptional factor 6 (ATF6) branches. Treatment with GSK2606414, a specific PERK inhibitor, significantly inhibited MeHg-induced cell death. These findings suggest that MeHg exquisitely regulates UPR signaling involved in cell death.
- 1 January 2017
- Published by Pharmaceutical Society of Japan in Biological and Pharmaceutical Bulletin
- Vol. 40 (9) , 1595-1598
Open AccessModulation of Unfolded Protein Response by Methylmercury
Methylmercury (MeHg) results in cell death through endoplasmic reticulum (ER) stress. Previously, we reported that MeHg induces S-mercuration at cysteine 383 or 386 in protein disulfide isomerase (PDI), and this modification induces the loss of enzymatic activity. Because PDI is a key enzyme for the maturation of nascent protein harboring a disulfide bond, the disruption in PDI function by MeHg results in ER stress via the accumulation of misfolded proteins. However, the effects of MeHg on unfolded protein response (UPR) sensors and their signaling remain unclear. In the present study, we show that UPR is regulated by MeHg. We found that MeHg specifically attenuated inositol-requiring enzyme 1α (IRE1α)–x-box binding protein 1 (XBP1) branch, but not the protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating transcriptional factor 6 (ATF6) branches. Treatment with GSK2606414, a specific PERK inhibitor, significantly inhibited MeHg-induced cell death. These findings suggest that MeHg exquisitely regulates UPR signaling involved in cell death.